Fsd Pharma Class Stock Target Price
HUGEDelisted Stock | USD 0.09 0 4.56% |
FSD Pharma Class fundamentals help investors to digest information that contributes to FSD Pharma's financial success or failures. It also enables traders to predict the movement of FSD Stock. The fundamental analysis module provides a way to measure FSD Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FSD Pharma stock.
FSD |
FSD Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FSD Pharma's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FSD Pharma could also be used in its relative valuation, which is a method of valuing FSD Pharma by comparing valuation metrics of similar companies.FSD Pharma is currently under evaluation in target price category among its peers.
FSD Fundamentals
Return On Equity | -0.64 | |||
Return On Asset | -0.34 | |||
Current Valuation | 4.57 M | |||
Shares Outstanding | 46.06 M | |||
Shares Owned By Insiders | 9.74 % | |||
Shares Owned By Institutions | 2.81 % | |||
Number Of Shares Shorted | 176.97 K | |||
Price To Earning | (1.53) X | |||
Price To Book | 0.50 X | |||
Price To Sales | 91.86 X | |||
Gross Profit | (3.33 M) | |||
EBITDA | (17.38 M) | |||
Net Income | (18.56 M) | |||
Cash And Equivalents | 31.62 M | |||
Cash Per Share | 0.83 X | |||
Total Debt | 337.46 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 3.98 X | |||
Book Value Per Share | 0.30 X | |||
Cash Flow From Operations | (11.03 M) | |||
Short Ratio | 0.11 X | |||
Earnings Per Share | (0.25) X | |||
Target Price | 2.6 | |||
Number Of Employees | 10 | |||
Beta | 0.85 | |||
Market Capitalization | 4.65 M | |||
Total Asset | 17.39 M | |||
Retained Earnings | (157.1 M) | |||
Working Capital | 6.52 M | |||
Current Asset | 3 M | |||
Current Liabilities | 13 M | |||
Net Asset | 17.39 M |
About FSD Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FSD Pharma Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FSD Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FSD Pharma Class based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |